Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 14

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship

Madison, Annelise A., Andridge, Rebecca, Kantaras, Anthony H., Renna, Megan E., Bennett, Jeanette M., Alfano, Catherine M., Povoski, Stephen P., Agnese, Doreen M., Lustberg, Maryam, Wesolowski, Robert, Carson, William E., Williams, Nicole O., Reinbolt, Raquel E., Sardesai, Sagar D., Noonan, Anne M., Stover, Daniel G., Cherian, Mathew A., Malarkey, William B., Kiecolt-Glaser, Janice K.·2023·Cancers
DOI 10.3390/cancers15174414
Open this paper in CoChat — free account

Abstract

About one-in-three breast cancer survivors have lingering cognitive complaints and objective cognitive impairment. Chronic inflammation and intestinal permeability (i.e., leaky gut), two risk factors for cognitive decline, can also fuel depression—another vulnerability for cognitive decline. The current study tested whether depression accompanied by high levels of inflammation or intestinal permeability predicted lower subjective and objective cognitive function in breast cancer survivors. We combined data from four breast cancer survivor studies (n = 613); some had repeated measurements for a total of 1015 study visits. All participants had a blood draw to obtain baseline measures of lipopolysaccharide binding protein—a measure of intestinal permeability, as well as three inflammatory markers that were incorporated into an inflammatory index: C-reactive protein, interleukin-6, and tumor necrosis factor-α. They reported depressive symptoms on the Center for Epidemiological Studies depression scale (CES-D), and a binary variable indicated clinically significant depressive symptoms (CES-D ≥ 16). The Kohli (749 observations) and the Breast Cancer Prevention Trial (591 observations) scales assessed subjective cognitive function. Objective cognitive function tests included the trail-making test, Hopkins verbal learning test, Conners continuous performance test, n-back test, FAS test, and animal-naming test (239–246 observations). Adjusting for education, age, BMI, cancer treatment type, time since treatment, study visit, and fatigue, women who had clinically elevated depressive symptoms accompanied by heightened inflammation or intestinal permeability reported poorer focus and marginally poorer memory. However, poorer performance across objective cognitive measures was not specific to inflammation-associated depression. Rather, there was some evidence of lower verbal fluency; poorer attention, verbal learning and memory, and working memory; and difficulties with visuospatial search among depressed survivors, regardless of inflammation. By themselves, inflammation and intestinal permeability less consistently predicted subjective or objective cognitive function. Breast cancer survivors with clinically significant depressive symptoms accompanied by either elevated inflammation or intestinal permeability may perceive greater cognitive difficulty, even though depression-related objective cognitive deficits may not be specific to inflammation- or leaky-gut-associated depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers15174414

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 67

  1. Joly, 2019, Long-Term Fatigue and Cognitive Disorders in Breast Cancer Survivors, Cancers, 11, 1896, 10.3390/cancers11121896 · DOI
  2. Dijkshoorn, 2021, Prevalence of Cognitive Impairment and Change in Patients with Breast Cancer: A Systematic Review of Longitudinal Studies, Psycho-Oncology, 30, 635, 10.1002/pon.5623 · DOI
  3. Bernstein, 2017, Cognitive Impairment in Breast Cancer Survivors Treated with Chemotherapy Depends on Control Group Type and Cognitive Domains Assessed: A Multilevel Meta-Analysis, Neurosci. Biobehav. Rev., 83, 417, 10.1016/j.neubiorev.2017.10.028 · DOI
  4. Whittaker, 2022, Prevalence of Cognitive Impairment Following Chemotherapy Treatment for Breast Cancer: A Systematic Review and Meta-Analysis, Sci. Rep., 12, 2135, 10.1038/s41598-022-05682-1 · DOI
  5. Boscher, C., Joly, F., Clarisse, B., Humbert, X., Grellard, J.-M., Binarelli, G., Tron, L., Licaj, I., and Lange, M. (2020). Perceived Cognitive Impairment in Breast Cancer Survivors and Its Relationships with Psychological Factors. Cancers, 12. · DOI
  6. Hutchinson, 2012, Objective and Subjective Cognitive Impairment Following Chemotherapy for Cancer: A Systematic Review, Cancer Treat. Rev., 38, 926, 10.1016/j.ctrv.2012.05.002 · DOI · Paper page
  7. Pullens, 2010, Subjective Cognitive Dysfunction in Breast Cancer Patients: A Systematic Review, Psycho-Oncology, 19, 1127, 10.1002/pon.1673 · DOI · Paper page
  8. Habermann, 2013, Impact of Perceived Cognitive Impairment in Breast Cancer Survivors, Eur. J. Oncol. Nurs., 17, 236, 10.1016/j.ejon.2012.06.002 · DOI · Paper page
  9. Savard, 2016, Subjective or Objective Measures of Cognitive Functioning—What’s More Important?, JAMA Oncol., 2, 1263, 10.1001/jamaoncol.2016.2047 · DOI
  10. Kohli, 2007, Self-Reported Cognitive Impairment in Patients with Cancer, J. Oncol. Pract., 3, 54, 10.1200/JOP.0722001 · DOI
  11. Tallman, 2015, Perceived Cognitive Function in Breast Cancer Survivors: Evaluating Relationships with Objective Cognitive Performance and Other Symptoms Using the Functional Assessment of Cancer Therapy—Cognitive Function Instrument, J. Pain Symptom Manag., 49, 697, 10.1016/j.jpainsymman.2014.08.012 · DOI
  12. Seliktar, 2015, Cognition in Breast Cancer Survivors: Hormones versus Depression, Psycho-Oncology, 24, 402, 10.1002/pon.3602 · DOI
  13. Jaremka, 2014, Cognitive Problems among Breast Cancer Survivors: Loneliness Enhances Risk, Psycho-Oncology, 23, 1356, 10.1002/pon.3544 · DOI
  14. American Psychiatric Association, D., and American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders: DSM-5, American Psychiatric Association. · DOI · Paper page
  15. Chang, 2012, Treatment Response and Cognitive Impairment in Major Depression: Association with C-Reactive Protein, Brain Behav. Immun., 26, 90, 10.1016/j.bbi.2011.07.239 · DOI · Paper page
  16. Carlier, 2021, Inflammation and Cognitive Functioning in Depressed Older Adults Treated with Electroconvulsive Therapy: A Prospective Cohort Study, J. Clin. Psychiatry, 82, 35808, 10.4088/JCP.20m13631 · DOI
  17. Krogh, 2014, The Association between Depressive Symptoms, Cognitive Function, and Inflammation in Major Depression, Brain Behav. Immun., 35, 70, 10.1016/j.bbi.2013.08.014 · DOI
  18. Carroll, 2023, Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living with Cancer Study, J. Clin. Oncol., 41, 295, 10.1200/JCO.22.00406 · DOI · Paper page
  19. Camilleri, 2019, Leaky Gut: Mechanisms, Measurement and Clinical Implications in Humans, Gut, 68, 1516, 10.1136/gutjnl-2019-318427 · DOI · Paper page
  20. Madison, 2020, Endotoxemia Coupled with Heightened Inflammation Predicts Future Depressive Symptoms, Psychoneuroendocrinology, 122, 104864, 10.1016/j.psyneuen.2020.104864 · DOI
  21. Madison, 2020, Afternoon Distraction: A High-Saturated-Fat Meal and Endotoxemia Impact Postmeal Attention in a Randomized Crossover Trial, Am. J. Clin. Nutr., 111, 1150, 10.1093/ajcn/nqaa085 · DOI
  22. Blasco, 2017, Neuroinflammation in Obesity: Circulating Lipopolysaccharide-Binding Protein Associates with Brain Structure and Cognitive Performance, Int. J. Obes., 41, 1627, 10.1038/ijo.2017.162 · DOI
  23. Bennett, 2014, Yoga’s Impact on Inflammation, Mood, and Fatigue in Breast Cancer Survivors: A Randomized Controlled Trial, J. Clin. Oncol., 32, 1040, 10.1200/JCO.2013.51.8860 · DOI · Paper page
  24. Renna, 2022, Breast Cancer Survivors’ Vaccine Responses: Chemotherapy, Obesity, and Fitness Make a Difference, Brain Behav. Immun., 103, 1, 10.1016/j.bbi.2022.03.019 · DOI
  25. Madison, A.A., Filatov, M., Andridge, R., Haas, G., Povoski, S.P., Agnese, D.M., Lustberg, M., Reinbolt, R.E., Wesolowski, R., and Williams, N.O. (2023). A Troubled Heart: Mood Disorder History Longitudinally Predicts Faster Cardiopulmonary Aging in Breast Cancer Survivorship. PLoS ONE, 18. · DOI
  26. Terhorst, 2011, Evaluation of the Psychometric Properties of the BCPT Symptom Checklist with a Sample of Breast Cancer Patients before and after Adjuvant Therapy, Psycho-Oncology, 20, 961, 10.1002/pon.1806 · DOI
  27. Lin, 2021, Trail Making Test Performance Using a Touch-Sensitive Tablet: Behavioral Kinematics and Electroencephalography, Front. Hum. Neurosci., 15, 663463, 10.3389/fnhum.2021.663463 · DOI
  28. Kortte, 2002, The Trail Making Test, Part B: Cognitive Flexibility or Ability to Maintain Set?, Appl. Neuropsychol., 9, 106, 10.1207/S15324826AN0902_5 · DOI · Paper page
  29. Small, 2012, The Diagnostic Value of Controlled Oral Word Association Test-FAS and Category Fluency in Single-Domain Amnestic Mild Cognitive Impairment, Dement. Geriatr. Cogn. Disord., 32, 235
  30. Campagna, 2017, The Animal Naming Test: An Easy Tool for the Assessment of Hepatic Encephalopathy, Hepatology, 66, 198, 10.1002/hep.29146 · DOI
  31. Conners, C.K. (2014). Conners Continuous Performance Test 3rd Edition (Conners CPT 3) & Connors Continuous Auditory Test of Attention (Conners CATA): Technical Manual, MHS.
  32. Scimeca, 2021, Examining Conners Continuous Performance Test-3 (CPT-3) Embedded Performance Validity Indicators in an Adult Clinical Sample Referred for ADHD Evaluation, Dev. Neuropsychol., 46, 347, 10.1080/87565641.2021.1951270 · DOI
  33. Rabin, 2005, Assessment Practices of Clinical Neuropsychologists in the United States and Canada: A Survey of INS, NAN, and APA Division 40 Members, Arch. Clin. Neuropsychol., 20, 33, 10.1016/j.acn.2004.02.005 · DOI · Paper page
  34. Benedict, 1998, Hopkins Verbal Learning Test–Revised: Normative Data and Analysis of Inter-Form and Test-Retest Reliability, Clin. Neuropsychol., 12, 43, 10.1076/clin.12.1.43.1726 · DOI · Paper page
  35. Chiaravalloti, 2005, Treating Learning Impairments Improves Memory Performance in Multiple Sclerosis: A Randomized Clinical Trial, Mult. Scler. J., 11, 58, 10.1191/1352458505ms1118oa · DOI
  36. Radloff, 1977, The CES-D Scale: A Self-Report Depression Scale for Research in the General Population, Appl. Psychol. Meas., 1, 385, 10.1177/014662167700100306 · DOI · Paper page
  37. Weissman, 1977, Assessing Depressive Symptoms in Five Psychiatric Populations: A Validation Study, Am. J. Epidemiol., 106, 203, 10.1093/oxfordjournals.aje.a112455 · DOI · Paper page
  38. Fontes, 2013, Clinical Correlates of Change in Inflammatory Biomarkers: The Framingham Heart Study, Atherosclerosis, 228, 217, 10.1016/j.atherosclerosis.2013.01.019 · DOI
  39. Kell, 2015, On the Translocation of Bacteria and Their Lipopolysaccharides between Blood and Peripheral Locations in Chronic, Inflammatory Diseases: The Central Roles of LPS and LPS-Induced Cell Death, Integr. Biol., 7, 1339, 10.1039/c5ib00158g · DOI
  40. Brenchley, 2006, Microbial Translocation Is a Cause of Systemic Immune Activation in Chronic HIV Infection, Nat. Med., 12, 1365, 10.1038/nm1511 · DOI · Paper page
  41. Gonzalez-Quintela, A., Alonso, M., Campos, J., Vizcaino, L., Loidi, L., and Gude, F. (2013). Determinants of Serum Concentrations of Lipopolysaccharide-Binding Protein (LBP) in the Adult Population: The Role of Obesity. PLoS ONE, 8. · DOI
  42. Vallejo, 2013, Correlation Between Different Methods to Measure Microbial Translocation and Its Association with Immune Activation in Long-Term Suppressed HIV-1–Infected Individuals, JAIDS J. Acquir. Immune Defic. Syndr., 64, 149, 10.1097/QAI.0b013e31829a2f12 · DOI
  43. Uhde, 2016, Intestinal Cell Damage and Systemic Immune Activation in Individuals Reporting Sensitivity to Wheat in the Absence of Coeliac Disease, Gut, 65, 1930, 10.1136/gutjnl-2016-311964 · DOI
  44. Tremellen, 2020, Small Intestinal Bacterial Overgrowth (SIBO) as a Potential Cause of Impaired Spermatogenesis, Gut, 69, 2058, 10.1136/gutjnl-2020-320766 · DOI
  45. Lakatos, 2010, Serum Lipopolysaccharide-Binding Protein and Soluble CD14 Are Markers of Disease Activity in Patients with Crohn’s Disease, Inflamm. Bowel Dis., 17, 767, 10.1002/ibd.21402 · DOI
  46. Sanderman, 1996, Psychometric Qualities of the RAND 36-Item Health Survey 1.0: A Multidimensional Measure of General Health Status, Int. J. Behav. Med., 3, 104, 10.1207/s15327558ijbm0302_2 · DOI · Paper page
  47. Walker, 2019, Systemic Inflammation during Midlife and Cognitive Change over 20 Years: The ARIC Study, Neurology, 92, e1256, 10.1212/WNL.0000000000007094 · DOI · Paper page
  48. Ellman, 2020, To Exclude or Not to Exclude: Considerations and Recommendations for C-Reactive Protein Values Higher than 10 Mg/L, Brain Behav. Immun., 87, 898, 10.1016/j.bbi.2020.01.023 · DOI
  49. Ballinger, 2004, Using Generalized Estimating Equations for Longitudinal Data Analysis, Organ. Res. Methods, 7, 127, 10.1177/1094428104263672 · DOI · Paper page
  50. Zeger, 1986, Longitudinal Data Analysis for Discrete and Continuous Outcomes, Biometrics, 42, 121, 10.2307/2531248 · DOI · Paper page
  51. Capuron, 2002, Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions, Neuropsychopharmacology, 26, 643, 10.1016/S0893-133X(01)00407-9 · DOI · Paper page
  52. Sundermann, 2017, Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer’s Disease Pathology in Women versus Men?, J. Alzheimer’s Dis., 56, 947, 10.3233/JAD-160716 · DOI
  53. Oliver, 2022, Subjective Cognitive Decline Is a Better Marker for Future Cognitive Decline in Females than in Males, Alzheimer’s Res. Ther., 14, 197, 10.1186/s13195-022-01138-w · DOI
  54. Ahmadi, 2020, Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis, J. Gerontol. Ser. A, 75, e9, 10.1093/gerona/glaa056 · DOI
  55. Ryan, 2001, Plasma Levels of Soluble CD14 and Tumor Necrosis Factor-α Type II Receptor Correlate with Cognitive Dysfunction during Human Immunodeficiency Virus Type 1 Infection, J. Infect. Dis., 184, 699, 10.1086/323036 · DOI
  56. Lyons, 2011, Plasma SCD14 Is a Biomarker Associated with Impaired Neurocognitive Test Performance in Attention and Learning Domains in HIV Infection, J. Acquir. Immune Defic. Syndr., 57, 371, 10.1097/QAI.0b013e3182237e54 · DOI
  57. Rundek, 2021, Gut Permeability and Cognitive Decline: A Pilot Investigation in the Northern Manhattan Study, Brain Behav. Immun.-Health, 12, 100214, 10.1016/j.bbih.2021.100214 · DOI
  58. Ufnal, 2017, The Gut-Blood Barrier Permeability—A New Marker in Cardiovascular and Metabolic Diseases?, Med. Hypotheses, 98, 35, 10.1016/j.mehy.2016.11.012 · DOI
  59. Zanoli, 2020, Vascular Consequences of Inflammation: A Position Statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society, J. Hypertens., 38, 1682, 10.1097/HJH.0000000000002508 · DOI
  60. Bradshaw, 2016, Cardiovascular Disease Mortality among Breast Cancer Survivors, Epidemiology, 27, 6, 10.1097/EDE.0000000000000394 · DOI · Paper page
  61. McAfoose, 2009, Evidence for a Cytokine Model of Cognitive Function, Neurosci. Biobehav. Rev., 33, 355, 10.1016/j.neubiorev.2008.10.005 · DOI · Paper page
  62. Turkheimer, 2023, Sickness Behaviour and Depression: An Updated Model of Peripheral-Central Immunity Interactions, Brain Behav. Immun., 111, 202, 10.1016/j.bbi.2023.03.031 · DOI
  63. Derry, 2015, Sex Differences in Depression: Does Inflammation Play a Role?, Curr. Psychiatry Rep., 17, 78, 10.1007/s11920-015-0618-5 · DOI
  64. Wang, 2020, Sex Differences in the Cognitive Function of First-Diagnosed, Drug-Naïve Depressed Patients: An Observational Case-Control Study, J. Affect. Disord., 276, 461, 10.1016/j.jad.2020.07.114 · DOI
  65. Madison, 2021, Omega-3 Supplementation and Stress Reactivity of Cellular Aging Biomarkers: An Ancillary Substudy of a Randomized, Controlled Trial in Midlife Adults, Mol. Psychiatry, 26, 3034, 10.1038/s41380-021-01077-2 · DOI
  66. Kaliannan, 2015, A Host-Microbiome Interaction Mediates the Opposing Effects of Omega-6 and Omega-3 Fatty Acids on Metabolic Endotoxemia, Sci. Rep., 5, 11276, 10.1038/srep11276 · DOI · Paper page
  67. Barnes, 2021, Omega-3 Fatty Acids Are Associated with Blood–Brain Barrier Integrity in a Healthy Aging Population, Brain Behav., 11, e2273, 10.1002/brb3.2273 · DOI · Paper page

Metadata

Authors
Madison, A. A., Andridge, R., Kantaras, A. H., Renna, M. E., Bennett, J. M., Alfano, C. M., Povoski, S. P., Agnese, D. M., Lustberg, M., Wesolowski, R., Carson, W. E., Williams, N. O., Reinbolt, R. E., Sardesai, S. D., Noonan, A. M., Stover, D. G., Cherian, M. A., Malarkey, W. B., & Kiecolt-Glaser, J. K.
Venue
Cancers
Publisher
MDPI AG
Published
2023-09-04
Volume
15
Issue
17
Pages
4414
ISSN
2072-6694
DOI
10.3390/cancers15174414
Cited by
14
References
14
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
NIH (R01 CA126857, R01 CA131029, R01 CA186251, R01CA186720, K05 CA172296, UL1RR025755, UL1TR002733, UL1TR001070, CA016058)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship. https://app.cochat.ai/papers/10.3390/cancers15174414
The paper
Madison, A. A., Andridge, R., Kantaras, A. H., Renna, M. E., Bennett, J. M., Alfano, C. M., Povoski, S. P., Agnese, D. M., Lustberg, M., Wesolowski, R., Carson, W. E., Williams, N. O., Reinbolt, R. E., Sardesai, S. D., Noonan, A. M., Stover, D. G., Cherian, M. A., Malarkey, W. B., & Kiecolt-Glaser, J. K. (2023). Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship. Cancers. https://doi.org/10.3390/cancers15174414

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.